Capitalised Intangible
Definition
An intangible investment — R&D, brand-build, customer-acquisition with measurable payback, software development — that has been moved from operating expense to balance-sheet asset and amortised over its useful life under management accounting. Statutory accounting rarely permits the same treatment for internally-generated intangibles: IAS 38 imposes six conservatism criteria that are difficult to meet in practice; ASC 730 forces immediate expensing under US GAAP. The valuation gap between statutory EBITDA and capitalisation-reclassified EBITDA — what the market would amortise if it were buying the asset — is the structural gap a management view of intangible investment makes visible. At a 7× multiple, every £1M reclassified to capitalisation typically widens enterprise value by £4M–£7M depending on amortisation period and Normative-EBIT calibration. The judgement management makes is how to present a management view alongside the statutory accounts: labelled, reconciled, and prepared on the same basis each period.
Taking a defensible position
The position
Whether an intangible investment is carried as an asset depends on the framework applied. Under IAS 38, development-phase expenditure may be carried forward where the six conditions in IAS 38.57 are demonstrated, while research-phase expenditure is written off under IAS 38.54. Under US GAAP, ASC 730 expenses research and development as incurred, apart from the software routes in ASC 350-40 and ASC 985-20.
A defensible posture
Presenting a management view of intangible investment alongside the statutory accounts is defensible provided the two are clearly labelled and reconciled. The posture that survives scrutiny states the basis used, applies it consistently across periods, and shows the bridge between the management figures and the reported ones. The posture that does not is a single adjusted earnings figure with no reconciliation behind it.
Evidence to hold
- A written statement of the management basis: which categories are capitalised, over what life, and on what reasoning.
- A reconciliation from statutory profit to the management view, line by line.
- Project-level spend records supporting each capitalised category.
- Prior-period figures prepared on the same basis, so the trend is comparable.
- Amortisation assumptions with the reasoning recorded for each useful life.
The challenge you may face
A buyer’s adviser will rebuild the numbers on their own assumptions, so expect the amortisation lives, the categories included and the treatment of recurring costs to be tested. The most common challenge is that spend recurring every year has been presented as investment; the second is that the management basis changed between periods, making the trend unreliable.
Complementary Terms
Concepts that frequently appear alongside Capitalised Intangible in practice.
Development costs are the expenditure incurred applying research findings to a plan or design for a new or substantially improved product, service, process or system before it enters commercial production or use. Under IAS 38 (IFRS — the default framework for UK groups reporting under adopted IFRS), the standard divides the work into two phases and treats them differently.
Internal-use software is software a business acquires or develops for its own operations rather than to sell or licence. Under US GAAP, ASC 350-40 sets a stage-based model.
An intangible asset created within the business (R&D output, brand, customer relationships, organisational know-how) rather than acquired through a transaction. IAS 38 conservatism rules make these difficult to capitalise on statutory books — six development-cost capitalisation criteria must all be met.
The International Accounting Standard governing the recognition, measurement, and disclosure of intangible assets. IAS 38 requires that an intangible asset be identifiable, controlled by the entity, and expected to generate future economic benefits.
The US GAAP standard requiring immediate expensing of research and development costs as incurred. ASC 730 is the structural source of the gap between statutory and capitalisation-reclassified EBITDA for US-headquartered companies: virtually no R&D is permitted on the balance sheet, regardless of stage, evidence quality, or commercial proximity.
Tony Hillier's framework for estimating expected EBIT given a company's identified intangible asset base, benchmarked against sector peers with comparable asset profiles. Distinct from Normalised EBIT, which strips one-off items, owner adjustments and non-recurring costs to show the underlying run-rate; Normative EBIT goes further and answers 'what should this business produce given its assets.' The gap between Normative and Actual EBIT is the core analytical output: positive gap (Normative > Actual) means the company is under-exploiting its asset base — upside for a PE acquirer; negative gap means actual performance is unsustainably ahead of the asset base, flagging key-person, market-timing, or contract-pricing risk.
An analytical framework that decomposes economic or firm-level output growth into contributions from labour, capital, and a residual factor often interpreted as technological progress or total factor productivity. Growth accounting is fundamental to understanding how intangible investments — in R&D, software, organisational design, and human capital — drive productivity improvements.
A reconciliation document that maps founder-reported EBITDA to a Fund's maintainable EBITDA, identifying each adjustment per IPEV Section 3.4 with documented evidence. The bridge typically traces non-recurring spend, discontinued lines, one-time items, founder compensation normalisation, and pro-forma adjustments — each with source documentation (board minutes, contracts, payroll) and the known-and-knowable evidence flag.
Put this knowledge to work
Use Opagio's free tools to measure and grow the intangible assets that drive your business value.